Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
primary studies published RCT
Details- 2025
- West NE
MetaNeb Versus Usual Care During Exacerbations of Cystic Fibrosis: An RCT.
primary studies published RCT
Details- 2025
- Chapman N
Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia.
primary studies published RCT
Details- 2025
- Schoop AC
Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): Results of a multi-centre randomised controlled trial.
primary studies published RCT
Details- 2025
- Plant BJ
The impact of probiotics on pulmonary, gastrointestinal, and growth outcomes in pediatric cystic fibrosis: a randomized controlled trial.
primary studies published RCT
Details- 2025
- Rahmani P
Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trial.
primary studies published RCT
Details- 2025
- Hameed S
Elexacaftor/tezacaftor/ivacaftor in children aged â¥6â years with cystic fibrosis heterozygous for F508del and a minimal function mutation: Results from a 96-week open-label extension study.
primary studies published RCT
Details- 2025
- Mall MA
The Effects of Progressive Muscle Relaxation on Mental Health and Sleep Quality in Adults with Cystic Fibrosis: A Randomized Controlled Trial.
primary studies published RCT
Details- 2025
- Maritescu A
Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study.
primary studies published RCT
Details- 2025
- Petraglia L
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
primary studies published RCT
Details- 2024
- Keating C